article thumbnail

Out of the Crisis #14: Robert Rhinehart on the Corona Initiative, accelerating basic research, and finding a cure faster

Startup Lessons Learned

A common test would be a viral entry or a viral attachment assay. These corporate raiders, and these leverage buyouts and this private equity hatchet bin. I needed it, other labs need it, I can provide it to them, but hey now, I'm on this interesting path of “is this what the future of viral vaccines looks like.”